CluePoints Newsroom

Serving up the latest news and information about CluePoints

View all of our News Articles
October 20, 2020 in Blog

Best Practice Advice to Enable Teams to Focus on High Quality Data in Clinical Studies

BioPharma studies are as vast as they are pioneering, with many different teams within many different groups across many organizations all playing a part in…
Read More
September 22, 2020 in Blog, Uncategorized

Exploring the role of AI and Machine Learning in Clinical Trials

We live in a rapidly evolving digital era shaped by a continuous stream of pioneering technological advances. The world of clinical research is no exception,…
Read More
September 16, 2020 in Blog

Centralized Monitoring – How to Unlock the Treasure Chest of Analytical Insights

Chief Scientific Officer of CluePoints, Steve Young, discusses his thoughts on how Centralized monitoring has started to take off in the clinical trials industry even…
Read More
September 9, 2020 in Blog

Applying Risk-Based Quality Management to Investigator-Led Trials

Medical science is advancing at a never before seen rate, but costs are spiralling meaning clinical trials need to change if they are to ensure…
Read More
September 1, 2020 in Blog, News

CluePoints Joins Forces with Global Growth Investor Summit Partners to Expand Market Leadership Position in Risk-Based Quality Management

LOUVAIN-LA-NEUVE, BELGIUM; KING OF PRUSSIA, PA; and LONDON, UK (September 1, 2020) – CluePoints S.A., a provider of Risk-Based Study Execution (RBx) and Data Quality…
Read More
August 31, 2020 in Blog

From Risk-Based Monitoring to Risk-Based Quality Management

A review of FDA marketing submissions between 2000 and 2012 revealed roughly one- third (32%) of all first-cycle review failures (16% of submissions overall) were…
Read More
August 5, 2020 in Blog

Webinar: The Future of Clinical Trial Monitoring

In the wake of COVID-19, adoption of decentralized clinical research is taking off as sponsors explore ways to maintain continuity for existing studies while looking…
Read More
August 4, 2020 in Blog, News

Over 300 Clinical Studies Benefit from CluePoints’ COVID-19 Risk Management Support

Addressing COVID-19 Specific Regulatory Guidance and Ensuring Early Risk Detection   King of Prussia, PA  – August 4th, 2020: CluePoints, the premier provider of Risk-Based…
Read More
July 20, 2020 in Blog

New Paper: From RBM to RBQM – The Future of Risk-Based Trial Management

A review of FDA marketing submissions between 2000 and 2012 revealed roughly one-third (32%) of all first-cycle review failures (16% of submissions overall) were driven…
Read More
July 13, 2020 in Blog, News

CluePoints & DIA Webinar: How is the Industry Coping with the Move to Remote Monitoring?

On July 28, CluePoints is teaming up with DIA for a webinar to explore how the clinical research industry is coping with the move to…
Read More


Find out where we’re headed next.

Featured Whitepaper

ICH E6 (R2)

Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.

Learn More

Featured Webinar

ICH E6 (R2)

This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.

Learn More

We're Kind of a Big Deal.


Platform Users


Studies De-Risked


Issues Detected